Provider News
OncoLink Cancer Resource Home

 

 
OncoLink Cancer Resource Home

Provider News and Information  (update 6/23/10)

OncoLink Cancer Resource Home
Types of Cancer Home
OncoLink Cancer Resource
Cancer Treatment Information Physician List
OncoLink Cancer Resource
Coping with Cancer MCC Staff
OncoLink Cancer Resource
Cancer Clinical Trials Matching Service Provider News
OncoLink Cancer Resource
Cancer Resources and News Women's News
OncoLink Cancer Resource
Ask the Cancer Experts Men's News
OncoLink Cancer Resource
OncoLink Cancer Library Treatment Protocols
OncoLink Cancer Resource
Cancer and Oncology Sponsors Cancer Control Protocols
OncoLink Cancer Resource
Giving to Oncolink's Cancer Resources Radiation Oncology
About Oncolink's Cancer Resources Upcoming Protocols
OncoLink
Giving to Oncolink's Cancer Resources Closed Protocols
Giving to Oncolink's Cancer Resources Related Links
   
 


 

 

MCC Administration

Benjamin Marchello, M.D.                 Principal Investigator bmarchello@hocnr.com

Grant Harrer, MD                               Co-Principal Investigator drharrer@benefis.net

James Burke, MD                               NCCTG Group Lead jburke@billingsclinic.org

James Hueftle, MD                             SWOG Group Lead jhueftle@prodigy.net

Thomas Warr, MD                               NSABP Group Lead thomas.warr@gfclinic.com

John Schallenkamp, MD                      RTOG Group Lead     jschallenkamp@billingsclinic.org

David Myers, MD                                Cancer Control Group Lead dmyers01@gmail.com


News and Information


     Big Sky Oncology Update Conference Aug. 6 -7              Big Sky Brochure

Cooperative Group Meetings

NCCTG           Oct. 12-14, 2010                                            SWOG             Oct. 20-24, 2010                                        RTOG                                                                                                  NSABP                                                                                                                                                                                     See Cooperative Group websites for registration                                     Travel on this page for MCC policy and reimbursement information

                 

Common Toxicity Criteria Tables

RECIST Quick Reference Guide

 

New Protocols Opened  (Updated 6/23/10)

  

Travel  

MCC Travel Policy                                     Travel Request Form                                  Travel Reimbursement Form

Investigational Agents                      PMB Agent Distribution Policy

 

                      New Protocols              

                              Cancer Control 

                                            

           

                                   Prevention

NSABP P-5    Protocol   Fact Sheet    Statin Polyp Prevention Trial in Patients with Resected Colon Cancer

 

 
                                   Treatment

CTSU PR11  Schema   Protocol   A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer (START)

NCCTG N1031 Protocol   Randomized Phase II Trial of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer

NCCTG N0879  Protocol   A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma

 

 

 

 

 

 

OncoLink Cancer Resource Home